Valuation: ConvaTec Group PLC

Market Cap 6.02B 102B 5.15B 4.81B 4.41B 8.29B 576B 8.46B 57B 22.21B 288B 22.58B 22.09B 956B P/E 2026 *
24.2x
P/E 2027 * 16.9x
Enterprise Value 7.36B 125B 6.3B 5.89B 5.4B 10.15B 704B 10.35B 69.76B 27.18B 353B 27.64B 27.04B 1,170B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.62x
Free-Float
95.17%
Yield 2026 *
2.57%
Yield 2027 * 2.92%
1 year 59.76
Extreme 59.76
59.76
3 years 57.13
Extreme 57.13
74.97
5 years 57.13
Extreme 57.13
74.97
10 years 57.13
Extreme 57.13
74.97
Manager TitleAgeSince
Chief Executive Officer 62 2025-08-03
Director of Finance/CFO 51 2025-08-03
Chief Operating Officer - 2026-05-31
Director TitleAgeSince
Director/Board Member 71 2017-08-13
Chairman 78 2019-09-29
Director/Board Member 62 2020-03-01
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-.--% - - 6.13B
-0.25%+2.91%-13.04%+10.06% 198B
-1.94%+1.70%+2.67%+13.22% 120B
-0.76%+0.17%+6.78%+74.44% 60.51B
-0.69%-2.96%+27.89%+63.21% 53.64B
+0.01%+2.20%-5.26%-31.45% 51.1B
+0.38%-0.64%+11.52%-14.93% 33.92B
-3.92%-8.23% - - 29.75B
+0.28%+0.42%+43.23%-8.77% 24.83B
+4.23%-0.85%-7.52%+24.92% 23.01B
Average -0.39%-0.28%+8.29%+16.34% 66.14B
Weighted average by Cap. -0.66%+1.42%+1.18%+17.19%

Financials

2026 *2027 *
Net sales 2.56B 43.3B 2.19B 2.04B 1.87B 3.52B 245B 3.59B 24.22B 9.44B 123B 9.6B 9.39B 406B 2.73B 46.27B 2.34B 2.19B 2B 3.77B 261B 3.84B 25.89B 10.09B 131B 10.26B 10.03B 434B
Net income 248M 4.2B 213M 199M 182M 342M 23.76B 349M 2.35B 917M 11.9B 932M 912M 39.47B 360M 6.1B 308M 288M 264M 496M 34.45B 506M 3.41B 1.33B 17.26B 1.35B 1.32B 57.24B
Net Debt 1.35B 22.8B 1.15B 1.08B 987M 1.86B 129B 1.89B 12.75B 4.97B 64.51B 5.05B 4.94B 214B 1.15B 19.43B 982M 918M 842M 1.58B 110B 1.61B 10.87B 4.24B 54.99B 4.31B 4.21B 182B
Logo ConvaTec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
3.078USD
Average target price
4.033USD
Spread / Average Target
+31.05%

Quarterly revenue - Rate of surprise